… therapy for stage IA lung cancer, although a large-scale … is standard surgical treatment in
lung cancer surgery, even in … been applied in cases of early-stage lung cancer (<2 cm in size or …

… Lung cancer is the leading cause of cancer-related death worldwide. Approximately 85%–88%
of lung cancers are non–small cell lung cancer … of patients with lung cancer has improved …

… Lung cancer continues to be the leading cause of cancer death worldwide. Non-small cell
lung cancer (NSCLC) is the most common lung cancer type, … Total lesion glycolysis (TLG) has …

… To predict the outcome of patients with non-small cell lung cancer (NSCLC) the currently …
, the total lesion glycolysis (TLG) and the mean metabolic active volume (MATV) in NSCLC. …

… quantitative changes in global tumor glycolysis using PET-FDG Imaging. The visual
response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999; 2: 159–171. …

… whether the primary tumor SUVmax and total lesion glycolysis (TLG) measured on 18 F‐FDG
PET/CT have prognostic significance in patients with non–small‐cell lung cancer (NSCLC). …

… (MTV) and total lesion glycolysis (TLG), with respect to clinical outcomes in stage I non-small-cell
lung cancer (NSCLC) patients undergoing stereotactic body radiation therapy (SBRT). …

… Lung cancer is one of the most common cancers and a main … lung masses or nodules
were found in 29 of 106 lung … , primary lung cancer could not be differentiated from lung-to-lung …

Introduction: The purpose of this study was to evaluate the predictive role of quantitative
metabolic parameters using total lesion glycolysis (TLG) in 18 F-2-fluoro-2-deoxyglucose-…

The aim of the present study was to investigate the association between serum tumor markers
and the metabolic tumor volume (MTV) or total lesion glycolysis (TLG), as determined by …